Planning Strategies’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
OM
KCM
Planning Strategies's GOSS Position: Q3 2026 in Review
Planning Strategies reduced its Gossamer Bio (GOSS) stake by 8.6% in Q3 2026, selling an estimated $39 and leaving 32 shares worth $379. The position accounts for ﹤0.01% of the portfolio, ranked #987.
Planning Strategies first reported a position in GOSS in Q2 2026 and has held it in 2 quarters since. The position peaked at $455 in Q2 2026. 76 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.
- Planning Strategies held 32 shares of Gossamer Bio worth $379 as of Q3 2026.
- Planning Strategies sold 3 Gossamer Bio shares in Q3 2026, an estimated $39.
- Gossamer Bio made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #987 holding.
- Planning Strategies first reported a position in Gossamer Bio in Q2 2026 and has held it in 2 quarters since.
- Planning Strategies's Gossamer Bio position peaked at $455 in Q2 2026.
- 76 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.
Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.